-
An intensive one-on-one case management program helps people with AIDS stay adherent to their medication regime, avoid hospitalizations and emergency department visits, and learn to self-manage their disease.
-
The European market for devices used in vascular diagnosis and intervention is the second-largest worldwide after the U.S., and also is exhibiting rapid growth that in some cases rivals that in the U.S. market. The largest segment of the market, products used in percutaneous coronary intervention (PCI), continues to grow as advances in device technology allow expansion of indications for use to include increasingly complex lesions such as bifurcations an d small-diameter vessels.
-
The FDA said in a September 2005 report on implantable cardiac defribrillator (ICD) and pacemaker malfunctions that the annual number of ICDs implanted in the U.S. "increased from fewer than 10,000 implants in 1990 to close to 100,000 in 2002." However, the medical systems in other Western nations are apparently not quite as aggressive in making use of ICDs.
-
With its multibillion-dollar purchase of Guidant (Indianapolis) earlier this spring, Boston Scientific (Natick, Massachusetts) fully realized that it was taking on a heavy risk of large legal liability fees when, earlier this year, it acquired Guidant (Indianapolis).
-
Arrhythmia Research Technology (ART; Fitchburg, Massachusetts) reported entering into a research agreement with the University of Rochester (Rochester, New York) to participate in a National Institutes for Health-funded investigation into "Risk Stratification in MADITT II Type Patients.
-
Using positron emission tomography (PET), the medical isotope 15O-water and cold pressor tests, Japanese researchers reported at the Society of Nuclear Medicine's (SNM; Reston, Virginia) 53rd annual meeting in San Diego that they were able to detect the beginnings of atherosclerosis - before the disease became clinically evident.
-
While much of the focus thus far in evaluating the connection between refractory migraines and patent foramen ovales (PFOs) has been concentrated on a few companies - including NMT Medical (Boston), AGA Medical (Golden Valley, Minnesota) and
-
St. Jude Medical (St. Paul, Minnesota) said it has received regulatory and reimbursement approvals from Japan's Ministry of Health, Labor and Welfare for the EnSite system, a computer-based visualization and navigation tool used by physicians when treating patients with irregular heartbeats.
-
The Bracco Group (Milan, Italy) and Integrated Medical Solutions (Alexandria, Virginia) reported the formation of a new company, Integrated Cardiac Solutions (ICS), focused, the companies said...
-
Cardiogenesis (Foothills Ranch, California), a developer of surgical products and accessories used in angina-relieving procedures, named William Ab-bott senior vice president, CFO, secretary and treasurer.
